MedPath

Physical Activity, Air Pollution, and High Blood Pressure

Not Applicable
Completed
Conditions
Essential Hypertension
Interventions
Behavioral: Exercise
Registration Number
NCT05092672
Lead Sponsor
University of British Columbia
Brief Summary

The investigators are investigating the effects of traffic-related air pollution (TRAP) on the cardiovascular and pulmonary response to exercise in patients with hypertension using a real world randomized, crossover study design. Participants will be exposed to 2 conditions: a low TRAP environment and a high TRAP environment. Each exposure will consist of 30 min of moderate-intensity exercise. Cardiovascular and pulmonary health outcomes will be measured before, during, and up to 24 hours following exposures. A minimum washout period of 1 week will be used to minimize carryover effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  1. Age between 40-70 years of age
  2. Previously diagnosed with elevated blood pressure or hypertension by a physician
Exclusion Criteria
  1. Current or ex-smokers (abstinent for less than one year)
  2. Lives with an individual who currently smokes cigarettes, e-cigarettes (i.e., vaping), or cannabis
  3. Hormone replacement therapy use
  4. Currently on beta-blocker or angiotensin receptor blocker (ARB) therapy
  5. Currently using over the counter drugs or supplements that may alter cardiovascular measures (as per the principal investigator's discretion)
  6. Prior diagnosis of any other existing cardiovascular or pulmonary diseases and/or conditions (other than hypertension)
  7. Musculoskeletal injury or lower limb limitation preventing safe engagement in moderate-intensity exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low traffic-related air pollutionExerciseParticipants will exercise in an environment with low levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with high levels of traffic-related air pollution.
High traffic-related air pollution firstExerciseParticipants will exercise in an environment with high levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with low levels of traffic-related air pollution.
Primary Outcome Measures
NameTimeMethod
Change from Baseline Blood Pressure at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

MAP, SBP, and DBP

Secondary Outcome Measures
NameTimeMethod
24-Hour Blood Pressure24 hours post-exposure

MAP, SBP, and DBP

Change from Baseline Arterial Stiffness at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

Pulse wave velocity and augmentation index

Heart Rate VariabilityBaseline and up to 24 hours post-exposure

Indices of heart rate variability

Change from Baseline FEV1/FVC at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

FEV1/FVC ratio measured by spirometry

Change from Baseline Microvascular Responsiveness at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

Microvascular responsiveness (measured by near-infrared spectroscopy)

Change from Baseline FEV1 and FVC at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) measured by spirometry (in L)

Muscle Oxygen SaturationContinuously throughout the 30 minute exercise bouts (during exposure)

Muscle oxygen saturation (measured by near-infrared spectroscopy)

Change from Baseline FEF25-75 and PEFR at 2 Hours Post-ExposureBaseline and 2 hours post-exposure

Forced expiratory flow at 25-75% of forced vital capacity (FEF25-75) and peak expiratory flow rate (PEFR) measured by spirometry (in L/s)

Severity of SymptomsBaseline and 2 hours post-exposure

Severity of respiratory symptoms (e.g., dyspnea, cough, wheeze, chest tightness) and headache on a 0-5 scale

Trial Locations

Locations (1)

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath